Latest

18:23
【PATEO (02889.HK): Enters global supply system of leading international automaker, wins dual-brand 8295 platform vehicle designations】NewTimeSpace News: On 26 August 2026, PATEO (02889.HK) announced that it has entered the global supply system of a leading international automotive group for the first time, securing dual-brand designations covering the global models of a premium luxury brand and the export models of a mid-to-high-end brand, involving overseas markets including Europe, the Middle East and South America; the Company will provide high-end intelligent cockpit domain controllers and AI in-vehicle interaction systems based on Qualcomm's fourth-generation Snapdragon 8295 platform.
Tag： PATEO02889.HKBusiness Contract
18:21
【CANSINOBIO (06185.HK): Latest progress of mRNA technology platform, subsidiary signs co-development agreement for personalized therapeutic tumor vaccines】NewTimeSpace News: On 26 August 2026, CANSINOBIO (06185.HK) announced that its mRNA platform is advancing the development of therapeutic biological products and delivery systems, with mRNA vaccines for glioblastoma, rhabdomyosarcoma, cervical cancer and In Vivo CAR-related therapies all at an early stage; its subsidiary CanSino Shanghai has entered into a strategic cooperation framework agreement with Depushi (Hangzhou) Biotechnology for the co-development of mRNA personalized therapeutic tumor vaccines.
Tag： CANSINOBIO06185.HKR&D Progress
18:15
【CSPC PHARMA (01093.HK): SYS6090 granted FDA Fast Track designation for MSS/pMMR metastatic colorectal cancer】NewTimeSpace News: On 26 August 2026, CSPC PHARMA (01093.HK) announced that its first-in-class PD-1/IL-15 bispecific fusion protein SYS6090 (JMT108) has been granted Fast Track designation by the US FDA for the treatment of MSS/pMMR metastatic colorectal cancer (mCRC) that has progressed after prior standard systemic therapy; the product has the potential to selectively remodel the immunologically "cold" tumor microenvironment and activate exhausted effector cells.
Tag： CSPC PHARMA01093.HKR&D Progress
18:13
【PRUDENTIAL (02378.HK): Subsidiary proposes to sell up to 2.0% stake in ICICI Prudential Asset Management to meet Indian public shareholding requirements】NewTimeSpace News: On 26 August 2026, PRUDENTIAL (02378.HK) announced that its subsidiary PCHL proposes to sell up to 2.0% of its shareholding in IPAMC through the open market, expected to take place on 27 August 2026, to assist IPAMC in meeting India's minimum public shareholding requirement (15% within five years after the IPO); upon completion, PCHL will retain a 32.6% stake in IPAMC with its governance rights unchanged.
Tag： PRUDENTIAL02378.HKPublic Float
18:08
【CSPC PHARMA (01093.HK): SYS6010 meets primary endpoint in Phase III study for EGFR-mutant NSCLC after EGFR TKI failure】NewTimeSpace News: On 26 August 2026, CSPC PHARMA (01093.HK) announced that its EGFR-targeting ADC SYS6010 has met the pre-specified primary endpoint of progression-free survival (PFS) in the Phase III study SYNSTAR-01 in EGFR-mutant locally advanced or metastatic NSCLC after EGFR TKI failure, as assessed by the IDMC, with PFS significantly superior to platinum-based chemotherapy with statistical significance and clinical meaningfulness, an observed trend of overall survival benefit, and a favorable overall safety profile.
Tag： CSPC PHARMA01093.HKR&D ProgressClinical Trial
18:02
【CHINA FOODS (00506.HK): Senior management plans to purchase 1,000,000 shares on the open market within two months】NewTimeSpace News: On 26 August 2026, CHINA FOODS (00506.HK) announced that its senior management (including executive directors), based on their confidence in the Company's business prospects and long-term investment value, plans to purchase an aggregate of 1,000,000 shares of the Company in open market transactions within two months from the date of the announcement; the purchases will strictly comply with the Listing Rules and the Company's securities trading policy, and the plan is subject to risks of being unable or partially unable to be implemented.
Tag： CHINA FOODS00506.HKShare Increase
18:02
【HANSOH PHARMA(03692.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 4.26 billion, YoY increase of 35.82%】NewTimeSpace News: August 26, 2026, HANSOH PHARMA(03692.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 8.3 billion, increased by 11.71% YoY.
Tag： HANSOH PHARMA03692.HKprofit growth
17:52
【HK Stock Connect Daily Report: HSI Quarterly Review Sparks HKD 38.6 Billion Fund-Flow Expectation; Jack Ma Boosts Alibaba Stake by Over HKD 600 Million in Consecutive Days - 20260826】On August 26, the three major Hong Kong indices rose collectively, with the Hang Seng Index up 0.56% to 25,652.97 points, the Hang Seng TECH Index up 0.82%, and turnover at HKD 254.824 billion. Copper-mining stocks led the gains, with JIANGXI COPPER up 9.92% as London copper hit a record closing high. Most China-concept brokerage stocks rose, with CICC up 8.25%. Quality-earnings stocks performed strongly, with INNOVENT BIO up 9.69% and ANTA SPORTS up 9.53%. Oil & gas stocks came under broad pressure. Southbound capital recorded a net buy of HKD 6.453 billion. SPDB International forecast the HSI quarterly review to trigger HKD 38.6 billion in fund flows, with 54 stocks likely to enter Stock Connect in September; Jack Ma boosted Alibaba stake by over HKD 600 million in consecutive days, and STAR SPORTS MED was included in the Hang Seng Composite Index.
Tag： HK Stock Connect Daily ReportCANSINOBIOYOFCFullgoal Hang Seng HK Equities Innovative Drugs And Health Care ETFChina Universal CNI HK Equities Innovative Drugs ETF
17:48
【GBA HOLDINGS (00261.HK): Completes Placing of 46.56 Million New Shares, Raising Approximately HKD 8.66 Million Net】NewTimeSpace News: On 26 August 2026, GBA HOLDINGS (00261.HK) announced the completion of a placing of 46.56 million new shares at HKD 0.20 each, raising approximately HKD 8.66 million net (approximately 14.05% of the enlarged share capital), with proceeds earmarked for expanding its financial and corporate advisory businesses and general working capital.
Tag： GBA HOLDINGS00261.HK
17:44
【C FIN SERVICES (00605.HK): Subsidiary Grants Loan of RMB 10 Million】NewTimeSpace News: On 26 August 2026, C FIN SERVICES (00605.HK) announced that its subsidiary Shenzhen Lingda Microfinance granted a loan of RMB 10 million for six months at 24% per annum, secured by two commercial properties in Shenzhen Futian.
Tag： C FIN SERVICES00605.HKTreasury Management
17:43
【SUNHO BIO-B (02898.HK): Possible delay in publishing 2026 interim results and interim report, trading suspension continues】NewTimeSpace News: On 26 August 2026, SUNHO BIO-B (02898.HK) announced that, as the publication of the 2025 annual results is still in progress, the 2026 interim results will be delayed beyond the 31 August 2026 deadline, with the interim report also likely to be delayed; the Company's shares have been suspended since 1 April 2026 and will remain suspended until all resumption guidance has been fulfilled.
Tag： SUNHO BIO-B02898.HKDelay
17:40
【CENTURY GINWA (00162.HK): Appoints Two Independent Non-Executive Directors and Adjusts Board Committees】NewTimeSpace News: On 26 August 2026, CENTURY GINWA (00162.HK) announced the appointment of Lv Haiying as independent non-executive director and remuneration committee chairman (annual fee of RMB 100,000) and Feng Ju as independent non-executive director and audit committee member (annual fee of HKD 120,000), restoring compliance with board composition requirements.
Tag： CENTURY GINWA00162.HKBoard Change
17:32
【SENSETIME-W(00020.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 607.42 million, turned profitable from a loss YoY】NewTimeSpace News: August 26, 2026, SENSETIME-W(00020.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 2.91 billion, increased by 23.44% YoY.
Tag： SENSETIME-W00020.HKturned profitable from a loss
17:32
【LUZHU BIOTECH-B(02480.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 61.62 million, loss narrowed by 20.56% YoY】NewTimeSpace News: August 26, 2026, LUZHU BIOTECH-B(02480.HK) released its Interim Report for the period ended December 31, 2026.
Tag： LUZHU BIOTECH-B02480.HKloss narrowed
17:32
【MIDLAND HOLDING(01200.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 282.09 million, YoY increase of 86.33%】NewTimeSpace News: August 26, 2026, MIDLAND HOLDING(01200.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 3.31 billion, increased by 31.52% YoY.
Tag： MIDLAND HOLDING01200.HKprofit growth
17:32
【CHINACOMSERVICE(00552.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 1.97 billion, YoY decrease of 7.46%】NewTimeSpace News: August 26, 2026, CHINACOMSERVICE(00552.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 74.48 billion, decreased by 3.2% YoY.
Tag： CHINACOMSERVICE00552.HKProfit declined
17:32
【DA MING INT'L(01090.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 23.82 million, YoY increase of 214.29%】NewTimeSpace News: August 26, 2026, DA MING INT'L(01090.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 21.9 billion, increased by 3.32% YoY.
Tag： DA MING INTL01090.HKprofit growth
17:32
【HUNG HING PRINT(00450.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 61.15 million, loss widened by 25.35% YoY】NewTimeSpace News: August 26, 2026, HUNG HING PRINT(00450.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 1.03 billion, increased by 10.51% YoY.
Tag： HUNG HING PRINT00450.HKLoss widens
17:32
【ONE MEDIA GROUP(00426.HK): FY 26/27 Q1 Report - Profit Attributable to Shareholders stood at loss of HKD 7.14 million, loss widened by 29.27% YoY】NewTimeSpace News: August 26, 2026, ONE MEDIA GROUP(00426.HK) released its Q1 Report for the period ended March 31, 2027, Total Revenue stood at HKD 6.37 million, decreased by 39.09% YoY.
Tag： ONE MEDIA GROUP00426.HKLoss widens
17:12
【UNI MEDICAL (02666.HK): Subsidiary completes issuance of RMB 250 million two-year onshore medium-term notes at coupon rate of 1.73%】NewTimeSpace News: On 26 August 2026, UNI MEDICAL (02666.HK) announced that its wholly owned subsidiary China Universal Leasing completed the issuance of the 2026 second tranche onshore medium-term notes on 25 August 2026, with an actual issuance amount of RMB 250 million, a two-year tenor, a fixed coupon rate of 1.73% and an issue price of RMB 100.0 per note (100% of face value).
Tag： UNI MEDICAL02666.HKDebt Issuance
Previous1..3031 323334..492     492 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments